Page 1 | Search Results | Hematology, ASH Education Program

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Evidence-Based Minireview: Does achieving MRD negativity after initial therapy improve prognosis for high-risk myeloma patients?

Surbhi Sidana, Elisabet Manasanch

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 142–147.

https://doi.org/10.1182/hematology.2019000075

Published: 2019

Journal Articles

Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients

Sergio Giralt, Eric Seifter

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 103–109.

https://doi.org/10.1182/asheducation-2018.1.103

Published: 2018

Journal Articles

Management of multiple myeloma in the relapsed/refractory patient

Pieter Sonneveld

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 508–517.

https://doi.org/10.1182/asheducation-2017.1.508

Published: 2017

Journal Articles

Sequencing of nontransplant treatments in multiple myeloma patients with active disease

Andrew J. Yee, Noopur S. Raje

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 495–503.

https://doi.org/10.1182/asheducation-2016.1.495

Published: 2016

Journal Articles

Multiple myeloma: a model for scientific and clinical progress

Jesus San Miguel

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 1–7.

https://doi.org/10.1182/asheducation-2014.1.1

Published: 2014

Journal Articles

A practical approach to relapsed multiple myeloma

Joseph R. Mikhael

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 262–267.

https://doi.org/10.1182/asheducation-2014.1.262

Published: 2014

Journal Articles

Novel therapies for relapsed myeloma

A. Keith Stewart

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 578–586.

https://doi.org/10.1182/asheducation-2009.1.578

Published: 2009

NARROW

Evidence-Based Minireview: Does achieving MRD negativity after initial therapy improve prognosis for high-risk myeloma patients?

Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients

Management of multiple myeloma in the relapsed/refractory patient

Sequencing of nontransplant treatments in multiple myeloma patients with active disease

Multiple myeloma: a model for scientific and clinical progress

A practical approach to relapsed multiple myeloma

Novel therapies for relapsed myeloma

ASH Publications

American Society of Hematology

Evidence-Based Minireview: Does achieving MRD negativity after initial therapy improve prognosis for high-risk myeloma patients?

Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients

Management of multiple myeloma in the relapsed/refractory patient

Sequencing of nontransplant treatments in multiple myeloma patients with active disease

Multiple myeloma: a model for scientific and clinical progress

A practical approach to relapsed multiple myeloma

Novel therapies for relapsed myeloma

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only